Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Voltarol ONE A DAY 140 mg Medicated plaster
⚠ This medicine appears to have been discontinued
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Diclofenac sodium may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
What it is and what it is used for
for Voltarol ONE A DAY Medicated Plaster is a medicine that relieves pain. It belongs to a group of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs). Voltarol ONE A DAY Medicated Plaster is used for the local symptomatic short-term treatment (max. 7 days) of pain associated with acute strains, sprains or bruises on the arms and legs as a result of blunt injuries in adolescents from 16 years of age and adults.
What you need to know before you take it
e Voltarol ONE A DAY Medicated Plaster Do not use Voltarol ONE A DAY Medicated Plaster
- if you are allergic to diclofenac or any of the other ingredients of this medicine (listed in section 6);
- if you are allergic to any other non-steroidal anti-inflammatory drug (NSAID, e.g. acetylsalicylic acid or ibuprofen);
- if you have ever developed asthma attacks, hives or swelling and irritation inside the nose after taking acetylsalicylic acid or any other NSAID;
- if you are suffering from an active stomach or duodenal ulcer;
- on injured skin (e.g. skin abrasions, cuts, burns), infected skin or skin affected by inflammation (exudative dermatitis) or eczema.
- if you are in the last three months of pregnancy;
- if you are a child or an adolescent younger than 16 years of age. Warnings and precautions Talk to your doctor or pharmacist before using Voltarol ONE A DAY Medicated Plaster
- if you suffer or have previously suffered from bronchial asthma or allergies; you may experience a bronchial muscle cramp (bronchospasm), which makes breathing difficult.
- if you notice a skin rash that develops after applying the medicated plaster. If this happens, immediately remove the medicated plaster and stop the treatment.
- if you suffer from disorders of the kidneys, heart or liver, or have previously suffered from a stomach or intestinal ulcer or intestinal inflammation or a tendency to bleeding.
Side effects can be reduced by using the lowest effective dose for the shortest possible period of time. Important precautions
- the medicated plaster must not come into contact with or be applied to the eyes or mucous membranes.
- elderly patients should use Voltarol ONE A DAY Medicated Plaster with caution because they are more likely to experience side effects. After taking off the medicated plaster, avoid exposing the treated area to direct sunlight or solarium radiation in order to reduce the risk of sensitivity to light. Do not use Voltarol ONE A DAY Medicated Plaster at the same time as any other diclofenac-containing or other non-steroidal pain-relieving and anti-inflammatory medicines regardless of whether these are used externally or taken by mouth. Children and adolescents Diclofenac is contraindicated for use in children and adolescents under 16 years of age. There are insufficient data of efficacy and safety available for children and adolescents below 16 years (see section Do not use Voltarol ONE A DAY Medicated Plaster). Other medicines and Voltarol ONE A DAY Medicated Plaster Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Provided that Voltarol ONE A DAY Medicated Plaster is used correctly, only a small amount of diclofenac is absorbed into the body so that the interactions described for diclofenac-containing medicines taken orally are unlikely to happen. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. Pregnancy In the first and second trimesters of pregnancy or if you want to become pregnant, Voltarol ONE A DAY Medicated Plaster should be used only after talking to your doctor. In the last trimester of pregnancy, Voltarol ONE A DAY Medicated Plaster must not be used because an increased risk of complications for the mother and the child cannot be ruled out (see "Do not use Voltarol ONE A DAY Medicated Plaster"). Breast-feeding Small quantities of diclofenac pass into the breast milk. Talk to your doctor before using Voltarol ONE A DAY Medicated Plaster during breast-feeding. In any case, if you are breast-feeding Voltarol ONE A DAY Medicated Plaster should not be applied directly onto the breast area. Oral forms (e.g. tablets) of diclofenac can cause adverse effects in your unborn baby. It is not known if the same risk applies to diclofenac when it is used on the skin. Driving and using machines Voltarol ONE A DAY Medicated Plaster has no influence on your ability to drive and use machines. Voltarol ONE A DAY Medicated Plaster contains butylated hydroxyanisole (E320) Butylated hydroxyanisole may cause local skin reactions (e.g. contact dermatitis), or irritation to the eyes and mucous membranes.
How to take it
Voltarol ONE A DAY Medicated Plaster Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one medicated plaster once daily. Attach one medicated plaster to the painful area. The maximum total daily dose is 1 medicated plaster a day, even if there is more than one injured area to be treated. Treat only one painful area at once. Method of administration For application on the skin (cutaneous use). Instructions for use: 1. Cut the sachet along the dotted line and remove the medicated plaster To apply the plaster: 2. Remove one of the two protective films.
3. Apply to the area to be treated and remove the remaining protective film.
4. Apply slight pressure with the palms of your hand until complete adhesion to the skin is achieved.
To remove the plaster: 5. Moisten the plaster with water and peel away an edge of the plaster and pull smoothly away from the skin. 6. To remove any product residues, wash the affected area with water gently rubbing the area with your fingers using a circular movement. If necessary, the medicated plaster can be held in place using a net bandage. Use the medicated plaster only on intact non-diseased skin. Do not use the medicated plaster together with an air-tight (occlusive) bandage. Do not wear it when bathing or showering. You should not divide the medicated plaster. Duration of use Do not use Voltarol ONE A DAY Medicated Plaster for longer than 7 days. If this medicine is required for more than 7 days for pain relief or if the symptoms worsen you are advised to consult a doctor. If you use more Voltarol ONE A DAY Medicated Plaster than you should Please tell your doctor if significant side effects occur after incorrect use of this medicine or accidental overdose (e.g. in children). He will be able to advise you of any action that may need to be taken. If you forget to use Voltarol ONE A DAY Medicated Plaster Do not use a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. Tell your doctor immediately and stop using the plaster if you notice any of the following: sudden itchy rash (hives); swelling of the hands, feet, ankles, face, lips, mouth or throat; difficulty breathing; drop in blood pressure or weakness. You may experience the following side effects: Common side effects (may affect up to 1 in 10 people): local skin reactions, such as skin redness, burning sensation, itching, inflamed skin redness, skin rash, sometimes with pustules or wheals. Very rare side effects (may affect up to 1 in 10,000 people): hypersensitivity reactions or local allergic reactions (contact dermatitis). In patients externally using medicines from the same active substance group as diclofenac, there have been isolated reports of generalised skin rash, hypersensitivity reactions such as swelling of the skin and mucous membranes and
anaphylactic-type reactions with acute circulatory regulation disorders and light sensitivity reactions. Absorption of diclofenac into the body by the skin is very low compared to the concentration of active substance in the blood following oral use of diclofenac. Therefore, the likelihood of side effects occurring in the body as a whole (such as gastrointestinal or kidney disturbances or difficulty breathing) is very low. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow card scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. By reporting side effects you can help provide more information on the safety of this medicine.
How to store it
Voltarol ONE A DAY Medicated Plaster Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and the sachet after "EXP". The expiry date refers to the last day of that month. Store in the original package in order to protect from light and moisture. Do not use Voltarol ONE A DAY Medicated Plaster if you notice that it is damaged. Used plasters should be folded in half with the sticky side inwards. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Contents of the pack and other information
What Voltarol ONE A DAY Medicated Plaster contains
- The active substance is diclofenac sodium. Each medicated plaster contains diclofenac as 140 mg diclofenac sodium.
- The other ingredients are: Backing layer: Polyester non-woven fabric Adhesive layer: Polyacrylate dispersion Tributyl citrate Butylhydroxyanisole Protective liner: Mono silicone coated paper What Voltarol ONE A DAY Medicated Plaster looks like and contents of the pack Voltarol ONE A DAY Medicated Plaster is a white 10×14 cm sized self-adhesive medicated plaster made of non-woven fabric on one and paper on other side. Voltarol ONE A DAY Medicated Plaster is available in packs of 2, 5, 7 and 10 medicated plasters, each in a single sachet. Not all pack sizes may be marketed. Marketing Authorisation Holder Haleon UK Trading Limited, The Heights, Weybridge, KT13 0NY, U.K. Manufacturer Fidia farmaceutici S.p.A., Via Ampere, 29, 20037 Paderno Dugnano (MI), Italy or GlaxoSmithKline Consumer Healthcare, GmbH & Co. KG, Barthstraße 4, 80339 München, Germany. This leaflet was prepared in May 2024.
33001755/B
Frequently asked questions about Voltarol ONE A DAY 140 mg Medicated plaster
What is the active substance in Voltarol ONE A DAY 140 mg Medicated plaster?
The active substance in Voltarol ONE A DAY 140 mg Medicated plaster is diclofenac sodium.
Are there equivalent medicines to Voltarol ONE A DAY 140 mg Medicated plaster?
Medicines with the same active substance, strength and form include: Voltarol 140mg Medicated Plaster. They are interchangeable only if your prescriber or pharmacist says so.
Where does this information come from?
This leaflet reproduces the patient information leaflet approved for Voltarol ONE A DAY 140 mg Medicated plaster, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Can I get Voltarol ONE A DAY 140 mg Medicated plaster without a prescription?
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
About this leaflet
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
- Source: electronic medicines compendium (emc), Datapharm
- Active substance: diclofenac sodium
- Official document: view the original leaflet on emc →
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
4.1. Therapeutic indications
Local symptomatic short-term treatment (max. 7 days) of pain in acute strains, sprains or bruises of the extremities following blunt trauma in adolescents from 16 years of age and adults.
4.2. Posology and method of administration
Posology
Adults and adolescents from 16 years of age
One medicated plaster should be applied to the painful area once daily. The maximum daily dose is 1 medicated plaster a day, even if there is more than one injured area to be treated. Therefore, only one painful area can be treated at a time.
Duration of use
Voltarol ONE A DAY Muscle Pain Relief 140 mg Medicated Plaster is to be used for the shortest duration necessary to control symptoms.
The duration of use should not exceed 7 days. The therapeutic benefit of longer use has not been established.
Elderly patients
This medicinal product should be used with caution in elderly patients who are more prone to adverse events (see also section 4.4).
Patients with renal or hepatic impairment
In treatment of patients with renal or hepatic impairment see section 4.4.
Paediatric population
The safety and efficacy of Voltarol ONE A DAY Muscle Pain Relief 140 mg Medicated Plaster in children and adolescents under 16 years of age has not been established (see also section 4.3).
If this medicinal product is required for more than 7 days for pain relief or if the symptoms worsen, the patient/parents of the adolescent is/are advised to consult a doctor.
Method of administration
Cutaneous use.
The medicated plaster must be applied only to intact non-diseased skin and should not be worn when bathing or showering.
The medicated plaster should not be divided.
If necessary, the medicated plaster can be held in place using a net bandage.
The medicated plaster must not be used together with an occlusive dressing.
4.3. Contraindications
- hypersensitivity to the active substance or to any of the excipients listed in section 6.1;
- hypersensitivity to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs [NSAIDs];
- patients who have previously experienced an asthma attack, urticaria or acute rhinitis when taking acetylsalicylic acid or any other non-steroidal anti-inflammatory drugs (NSAIDs);
- patients with active peptic ulcer;
- on damaged skin, whatever the lesion involved: exudative dermatitis, eczema, infected lesion, burn or wound;
- third trimester of pregnancy;
- children and adolescents aged less than 16 years.
4.4. Special warnings and precautions for use
The medicated plaster must not come into contact with or be applied to the eyes or mucous membranes.
Undesirable effects can be reduced by using the lowest effective dose for the shortest possible period of time (see section 4.2).
Bronchospasm can occur in patients who suffer or have previously suffered from bronchial asthma or allergies.
Treatment must be stopped immediately if a skin rash develops after applying the medicated plaster.
Patients should be warned against exposure to sunlight or solarium radiation after removal of the medicated plaster in order to reduce the risk of photosensitisation.
The possibility of systemic adverse events from application of diclofenac medicated plaster cannot be excluded if the preparation is used on large areas of skin and over a prolonged period.
Although the systemic effects are expected to be minimal, the medicated plasters should be used with caution in patients with impaired renal, cardiac or hepatic function, or a history of peptic ulcer, inflammatory bowel disease or haemorrhagic diathesis. Non-steroidal anti-inflammatory drugs should be used with caution in elderly patients as they are more likely to experience undesirable effects.
No other medicinal products containing diclofenac or any other non-steroidal anti-inflammatory drugs (NSAIDs) should be used concomitantly, neither topically nor systemically.
Butylated hydroxyanisole (E 320) may cause local skin reactions (e.g. contact dermatitis), or irritation to the eyes and mucous membranes.
4.5. Interaction with other medicinal products and other forms of interaction
Since systemic absorption of diclofenac during labelled use of the medicated plasters is very low, the risk of developing clinically relevant drug-drug interactions is negligible.
4.6. Fertility, pregnancy and lactation
Pregnancy
There is no clinical data from the use of diclofenac during pregnancy.
The systemic concentration of diclofenac is lower after topical administration, compared to oral formulations. Even if systemic exposure is lower compared with oral administration, it is not known if the systemic diclofenac exposure reached after topical administration can be harmful to an embryo/fetus. With reference to experience from treatment with NSAIDs with systemic uptake, the following is recommended:
Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk for cardiovascular malformation was increased from less than 1%, up to approximately 1.5 %. The risk is believed to increase with dose and duration of therapy. In animals, administration of a prostaglandin synthesis inhibitor has been shown to result in increased pre- and post-implantation loss and embryo-foetal lethality. In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during the organogenetic period.
During the first and second trimester of pregnancy, diclofenac should not be given unless clearly necessary. If diclofenac is used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.
During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to:
- cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension);
- renal dysfunction, which may progress to renal failure with oligo-hydroamniosis;
the mother and the neonate, at the end of pregnancy, to:
- possible prolongation of bleeding time, an anti-aggregating effect which may occur even at very low doses.
- inhibition of uterine contractions resulting in delayed or prolonged labour.
Consequently, diclofenac is contraindicated during the third trimester of pregnancy (see section 4.3).
Breast-feeding
Diclofenac passes into breast milk in small amounts. However, at therapeutic doses of diclofenac medicated plaster no effects on the breast-fed child are anticipated.
Because of a lack of controlled studies in breast-feeding women, the medicinal product should only be used during breast-feeding under advice from a healthcare professional. Under this circumstance, Voltarol Once-a-day 140 mg Plaster should not be applied on the breasts of breast-feeding mothers, nor elsewhere on large areas of skin or for a prolonged period of time.
4.7. Effects on ability to drive and use machines
Voltarol Once-a-day 140 mg Plaster has no influence on the ability to drive and use machines.
4.8. Undesirable effects
The following frequency categories are used for reporting undesirable effects:
Very common
≥ 1/10
Common
≥ 1/100 to <1/10
Uncommon
≥ 1/1,000 to <1/100
Rare
≥ 1/10,000 to <1/1,000
Very rare
<1/10,000
Not known
cannot be estimated from the available data
Infections and infestations
Very rare
Rash pustular
Immune system disorders
Very rare
Hypersensitivity (including urticaria), angioneurotic oedema, anaphylactic type reaction
Respiratory, thoracic and mediastinal disorders
Very rare
Asthma
Skin and subcutaneous tissue disorders
Common
Rash, eczema, erythema, dermatitis (including allergic and contact dermatitis), pruritus
Rare
Dermatitis bullous (e.g. erythema bullosum), dry skin
Very rare
Photosensitivity reaction
General disorders and administration site conditions
Common
Application site reactions
Systemic plasma diclofenac levels measured during labelled use of the medicated plasters are very low compared to those obtained after oral intake of diclofenac. The risk of developing systemically induced undesirable effects (like gastric, hepatic and renal disorders, systemic hypersensitivity reactions) during use of the plaster therefore appears to be low. However, in particular when the medicated plaster is used on a large area of skin and over a prolonged period of time, systemic undesirable effects may occur.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
4.9. Overdose
There is no experience with overdose of diclofenac medicated plaster.
Should significant systemic undesirable effects occur following incorrect use or accidental overdose (e.g. in children), the precautions appropriate for poisoning with non-steroidal anti-inflammatory drugs should be taken.
💬 Ask about this leaflet
Ask anything about Voltarol ONE A DAY 140 mg Medicated plaster. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
Medicines containing Diclofenac sodium
- Amgesic Pain Relief 1% w/w Gel
- Diclo-SR 75
- Diclofenac Glenmark 3% gel
- Diclofenac Sodium 100mg Suppositories
- Diclofenac sodium 3% gel
- Diclofenac sodium Dexcel SR 75 mg Prolonged-release Tablets
- Diclofenac sodium Dexcel XL 100 mg Prolonged-release Tablets
- Diclomax Retard Modified release capsules
- Diclomax SR Modified release capsules
- Econac 100 mg suppositories
- Solaraze 3% Gel
- Voltarol 100 mg Suppositories
- Voltarol 12.5 mg Suppositories
- Voltarol 140mg Medicated Plaster